BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  IN8bio to Present at Scientific Conferences in November: PEGS Europe, SITC and SNO

  IN8bio, Inc. today announced presentations at three scientific conferences in November. Event: Protein & Antibody Engineering Summit (PEGS) Europe

  November 4, 2021

   · 

  2 min read
• Drug Development

  Kazia Enrols First Patient to EVT801 Phase I Clinical Trial

  Kazia Therapeutics Limited, an oncology-focused drug development company, is pleased to announce that it has commenced enrolment to a phase I clinical trial of EVT801, an investigational cancer therapy that Kazia licensed from Evotec SE in April 2021.

  November 4, 2021

   · 

  5 min read
• InMode to Participate in Upcoming Virtual Investor Conferences in November

  InMode Ltd. today announced that Moshe Mizrahy , Chief Executive Officer and Yair Malca , Chief Financial Officer will participate in the following upcoming virtual investor conferences:

  November 4, 2021

   · 

  1 min read
• Business

  NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer

  NeuroBo Pharmaceuticals, Inc. today announced that the Company has appointed Gil Price, M.D. as President and Chief Executive Officer.

  November 4, 2021

   · 

  8 min read
• Drug Development

  NodThera Announces Progress of NT-0796, a Novel NLRP3 Inflammasome Inhibitor, into a Phase 1 First-in-Human Study

  NodThera today announced that the first healthy volunteers have been dosed in a Phase 1 clinical trial of its lead investigational candidate, NT-0796.

  November 4, 2021

   · 

  2 min read
• Biotech Bay

  Omnilux Cohosts November 9th Webcast with MedEsthetics Magazine

  Today, GlobalMed Technologies (GMT), the manufacturer of Omnilux™ LED devices for professional and home use, announces an upcoming free educational webcast

  November 4, 2021

   · 

  2 min read
• Business

  Akebia Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones

  Akebia Therapeutics®, Inc. today reported financial results for the third quarter ended September 30, 2021 and highlighted recent corporate milestones.

  November 4, 2021

   · 

  15 min read
• Biotech Bay

  ArsenalBio Announces Participation in Upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting

  ArsenalBio today announced that it will present pre-clinical data from AB-X, the company’s integrated circuit T cell therapy program for the treatment of ovarian cancer (OC), at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting taking place November 10-14, 2021

  November 4, 2021

   · 

  2 min read
• Business

  Inspirna Announces Clinical Collaboration with Bristol Myers Squibb to Study RGX-104 in Combination with Yervoy® (ipilimumab) for Treatment of Metastatic Endometrial Cancer

  Inspirna, Inc today announced a collaboration with Bristol Myers Squibb on a clinical trial of a combination therapy using RGX-104

  November 4, 2021

   · 

  4 min read
• Business

  Kadmon Provides Business Update and Reports Third Quarter 2021 Financial Results

  Kadmon Holdings, Inc. provided a business update and reported financial and operational results for the third quarter of 2021.

  November 4, 2021

   · 

  14 min read